Recent Finacing
Recent Raise
GlyProVac develops a maternal vaccine (GPV02) using BEMAP-enabled protein constructs with native sugar modifications to mimic E. coli surface antigens and elicit maternal antibodies protecting newborns from neonatal sepsis.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
